| 莫沙必利与坦洛新联合治疗糖尿病神经源性膀胱的疗效观察 |
| |
| 引用本文： | 王冬梅,任平香,田逸先,王久敏. 莫沙必利与坦洛新联合治疗糖尿病神经源性膀胱的疗效观察[J]. 临床合理用药杂志, 2013, 6(3): 53-54 |
| |
| 作者姓名： | 王冬梅 任平香 田逸先 王久敏 |
| |
| 作者单位： | 河北省唐山市丰润区人民医院内分泌科;河北省唐山市丰润区人民医院药剂科;唐山市丰润区中医院急诊科 |
| |
| 摘 要： | 目的观察莫沙必利与坦洛新联合治疗糖尿病神经源性膀胱的疗效。方法选取40例2型糖尿病神经源性膀胱患者,给予莫沙必利与坦洛新联合治疗4周,比较治疗前后B超膀胱残尿量的变化。结果治疗后B超测定的残尿量（52±6）ml较治疗前的（190±21）ml明显减少,差异有统计学意义（t=6.677,P〈0.05））。结论莫沙必利、坦洛新联合治疗糖尿病神经源性膀胱,可以明显改善尿潴留,有较好的临床疗效。
|
| 关 键 词： | 莫沙必利 坦洛新 糖尿病 治疗结果 |
Clinical Observation on Mosapride and Tamsuloin in Treating Diabetic Neurogenic Bladder |
| |
| Affiliation: | WANG Dong-mei,REN Ping-xiang,TIAN Yi-xian,et al.Tangshan City Fengrun District People’s Hospital,Tangshan 064000,China |
| |
| Abstract: | Objective To observe the efficacy of Mosapride and Tamsuloin in treating diabetic neurogenic bladder.Methods 40 pations with type2 diabetes and diabetic neurogenic bladder were treated with Mosapride and Tamsuloin for 4 weeks and The postvoiding residue of bladder measured by ultragonogram were compared befor and after therapy.Results The postvoiding residue of bladder after therapy（52±6）ml were significantly decreased than those before therapy（190±21）ml（t=6.677,P〈0.05）.Conclusion Mosapride and Tamsuloin can significantly improve the improve the postvoiding residue of bladder in pations with diabetic neurogenic bladder. |
| |
| Keywords: | Mosapride Tamsuloin Diabetes mellitus Treatment outcome |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
